Login / Signup

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis.

Hee-Young YoonJung Jin HwangDong Soon KimJin Woo Song
Published in: Orphanet journal of rare diseases (2018)
Low-dose sirolimus may stabilise lung function decline in lymphangioleiomyomatosis patients, but its efficacy appears to be inferior to that of conventional-dose sirolimus.
Keyphrases
  • low dose
  • lung function
  • end stage renal disease
  • high dose
  • cystic fibrosis
  • newly diagnosed
  • chronic obstructive pulmonary disease
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis